eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ARGX-Argenx SE

Argenx SE ARGX

$701.01-11.19(-1.57%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Argenx SE
Today
Create an eToro account to buy ARGX stock on a secure, user-friendly, multi-asset trading platform.
Buy Argenx SE
Buy Argenx SE
Argenx SE ARGX
Buy ARGX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
806.00
Based on analysts who covered ARGX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Argenx SE News

About Argenx SE
Argenx SE is a European clinical-stage biotechnology company based in Breda, The Netherlands and serving an international audience via offices in Ghent, Belgium, Boston, USA, and Tokyo, Japan. Founded in 2008, the firm is involved in the development of life-changing therapeutic treatments aimed at patients with a range of illnesses and conditions, including Acute Myeloid Leukaemia, Severe Autoimmunity, and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

The company is listed on the EN Brussels, where it trades under the stock ticker ARGX. As of January 2021, the ARGX price chart was showing a 52-week high of €259.20 and a 52-week low of €93.05, with a market cap of €13.09bn.

The firm has several projects in the pipeline at the pre-clinical phase and at all clinical phases, with a focus on discovering and developing life-changing immunology solutions for patients living with autoimmune diseases. It is involved in academic collaborations with several prestigious institutions, including Bern University, UCL, and Ludwig Cancer Research. Argenx SE has also created an antibody innovation ecosystem, allowing scientists and antibody engineers to work together on vital and innovative antibody research.

Looking to invest? To stay up-to-date on the value of this instrument, simply add ARGX stock to your eToro watchlist.
VIEW MORE   

ARGX Stock Price Chart

‎4.08‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Argenx SE share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Argenx SE share price today is $701.01, reflecting a ‎-1.57‎% change over the last 24 hours and ‎-0.94‎% over the past week. The current market capitalization of ARGX is $43.59B with an average volume in the last three months of 399126. The stock has a P/E ratio of 33.46 and a dividend yield of 0%. With the stock’s beta sitting at 0.63
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$43.59B
Day’s Range
i
Shows the high and low prices of the day.
$699.09 - $712.48
52W Range
i
Shows the high and low prices of the last year.
$349.33 - $713.98
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
399126
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
33.46
Revenue
i
The total income generated by this company’s goods and services last year.
$3.06B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
$0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$712.2
EPS
i
A company’s total earnings divided by the number of shares it has issued.
$21.29
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.63
What Is Argenx SE?
Argenx SE is a European clinical-stage biotechnology company based in Breda, The Netherlands and serving an international audience via offices in Ghent, Belgium, Boston, USA, and Tokyo, Japan. Founded in 2008, the firm is involved in the development of life-changing therapeutic treatments aimed at patients with a range of illnesses and conditions, including Acute Myeloid Leukaemia, Severe Autoimmunity, and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

The company is listed on the EN Brussels, where it trades under the stock ticker ARGX. As of January 2021, the ARGX price chart was showing a 52-week high of €259.20 and a 52-week low of €93.05, with a market cap of €13.09bn.

The firm has several projects in the pipeline at the pre-clinical phase and at all clinical phases, with a focus on discovering and developing life-changing immunology solutions for patients living with autoimmune diseases. It is involved in academic collaborations with several prestigious institutions, including Bern University, UCL, and Ludwig Cancer Research. Argenx SE has also created an antibody innovation ecosystem, allowing scientists and antibody engineers to work together on vital and innovative antibody research.

Looking to invest? To stay up-to-date on the value of this instrument, simply add ARGX stock to your eToro watchlist.
Buy ARGX

How can I buy Argenx SE stocks?

To purchase Argenx SE:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Argenx SE (ARGX) page and place an order to buy Argenx SE.
Buy ARGX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Argenx SE
Invest in Argenx SE
Today
Create an eToro account to buy ARGX stock on a secure, user-friendly, multi-asset trading platform.
Buy ARGX

FAQ

The current price of ARGX is $701.01.
The average price target for Argenx SE is $806.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Argenx SE based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Argenx SE is $43.59B
Based on 14 analysts offering recommendations for ARGX in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top